JHS2023-10-012023-12-31 JHS2023-10-012023-12-31 JHS2023-10-012023-12-31in-bse-fin:OneOperatingExpenses01Member JHS2023-10-012023-12-31in-bse-fin:FourOperatingExpenses01Member JHS2023-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 532771 JHS NOTLISTED JHS Svendgaard Laboratories Limited Equity 2023-04-01 2024-03-31 2024-02-14 2024-02-05 INR Lakhs Third quarter 12:58:00 17:35:00 2024-02-14 2024-02-14 Not applicable Single segment The Company is engaged In Manufacturing of oral care products 2023-10-01 2023-12-31 Unaudited Consolidated 143001000.00 23400000.00 166401000.00 65169000.00 10455000.00 887000.00 24664000.00 1068000.00 16250000.00 42411000.00 160904000.00 5497000.00 0.00 5497000.00 0.00 5371000.00 5371000.00 0.00 126000.00 0.00 0.00 0.00 0.00 126000.00 405000.00 531000.00 0.00 0.00 783968000.00 10 0.00 0.00 0.00 0.00 0.00 0.00 The consolidated financials results of the Group include financial results of a subsidiary namely JHS Svendgaard Mechanical and Warehouse Private Limited. The details of ownership is given as below :- 1.In line with the provisions of Ind AS 108 - Operating Segments and on the basis the review of operations being done by the Management, the operations of the Company fall under Manufacturing of Oral Care products, which is considered to be the only reportable segment by the management. 2. On the 22 September, 2023, the Board of Directors of the Company considered and approved the Scheme of Arrangement for Amalgamation of JHS Svendgaard Laboratories Limited (“Transferor Company”) with Vedic Cosmeceuticals Private Limited (“Transferee Company”) (“Scheme”), on a going concern basis, under the provisions of section 230-232 of the Companies Act, 2013 and the Rules made thereunder. Following the submissions, both stock exchanges raised several queries, which were promptly and comprehensively addressed. However, it's important to note that as of the current status, the No Objection Certificate (NOC) is still pending from both Stock Exchanges, as per Regulation 37 of SEBI (Listing Obligations and Disclosure Requirements), 2015. 3. The National Company Law Tribunal, Chandigarh Bench (“NCLT”) on 10 August, 2023, had approved the Composite Scheme of Arrangement between JHS Svendgaard Retail Ventures Private Limited ( Resulting Company ), JHS Svendgaard Brands Limited ( Transferor Company ) and JHS Svendgaard Laboratories Limited ( Demerged /Transferee Company ) and their respective shareholders and creditors (“Scheme”) under the provisions of Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (“Act”) read with the Rules framed thereunder. This Scheme is set to become effective as of the appointed date, which is the 1 April 2021 and the certified order copy was submitted to the concerned Registrar of Companies, on the 28 August 2023.As a result:a) The Transferor Company has been merged with the Transferee Company and its financial data shall not been consolidated in these financial results.b) On 12 September, 2023, Transferee Company issued 1,34,96,297 shares to the shareholders of Transferor Company in accordance with the ratio outlined in the scheme. At present, we have received the trading approval form the both Stock exchanges namely BSE and NSE dated on 07 February, 2024. c) The Resulting Company has been demerged and is no longer a subsidiary company. Its financials have also not been consolidated in these financial results and also, allotted 64,92,600 equity shares to the shareholders of JHS Svendgaard Laboratories Limited on the 12 September, 2023, in accordance with the scheme's specified ratio. The Corporate Action for 64,92,600 equity shares has been completed. Following the submissions, both stock exchanges raised several queries, which were promptly and comprehensively addressed. However, it's important to note that as of the current status, final listing approval is still pending from both Stock Exchanges. 4.As Stated above, pursuant to the requirements of Ind AS 103 Business Combination , the company has accounted merger by using pooling of interest method in the financial results in line with the Scheme. Accordingly the financial information presented for the prior periods has been restated as per Ind AS 103. 5.Figures for the quarter ended 31 December 2023 are the balancing figures between the unaudited year to date figures up to the third quarter of the respective financial year and the unaudited figures in respect of the second quarter of the respective financial year.8.Previous period figures have been re-grouped / re-classified wherever necessary, to conform to current period’s classification or also in order to comply with the requirements of the amended Schedule III to the Companies Act, 2013 effective 1 April 2021. Single segment 2023-04-01 2023-12-31 Unaudited Consolidated 491348000.00 29407000.00 520755000.00 264505000.00 18766000.00 11743000.00 67298000.00 3307000.00 44447000.00 146769000.00 556835000.00 -36080000.00 0.00 -36080000.00 0.00 -3023000.00 -3023000.00 0.00 -33057000.00 0.00 0.00 0.00 0.00 -33057000.00 1770000.00 -31287000.00 0.00 0.00 783968000.00 10 0.42 0.42 0.00 0.00 0.42 0.42 Other Expenses 42411000.00 Other Expenses 146769000.00 392000.00 622000.00 -797000.00 -2392000.00